Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 46


Individual immune selection pressure has limited impact on seasonal influenza virus evolution.

Han AX, Maurer-Stroh S, Russell CA.

Nat Ecol Evol. 2018 Dec 3. doi: 10.1038/s41559-018-0741-x. [Epub ahead of print]


Influenza Vaccine-Induced Antibody Responses Are Not Impaired by Frailty in the Community-Dwelling Elderly With Natural Influenza Exposure.

Narang V, Lu Y, Tan C, Camous XFN, Nyunt SZ, Carre C, Mok EWH, Wong G, Maurer-Stroh S, Abel B, Burdin N, Poidinger M, Tambyah PA, Bosco N, Visan L, Ng TP, Larbi A.

Front Immunol. 2018 Oct 24;9:2465. doi: 10.3389/fimmu.2018.02465. eCollection 2018.


Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors and status of novel antivirals, 2016-2017.

Lackenby A, Besselaar TG, Daniels RS, Fry A, Gregory V, Gubareva LV, Huang W, Hurt AC, Leang SK, Lee RTC, Lo J, Lollis L, Maurer-Stroh S, Odagiri T, Pereyaslov D, Takashita E, Wang D, Zhang W, Meijer A.

Antiviral Res. 2018 Sep;157:38-46. doi: 10.1016/j.antiviral.2018.07.001. Epub 2018 Jul 3.


Inter-Species Host Gene Expression Differences in Response to Human and Avian Influenza A Virus Strains.

Taye B, Yeo D, Lee RTC, Tan BH, Sugrue RJ, Maurer-Stroh S.

Int J Mol Sci. 2017 Nov 1;18(11). pii: E2295. doi: 10.3390/ijms18112295.


Prenylation of viral proteins by enzymes of the host: Virus-driven rationale for therapy with statins and FT/GGT1 inhibitors.

Marakasova ES, Eisenhaber B, Maurer-Stroh S, Eisenhaber F, Baranova A.

Bioessays. 2017 Oct;39(10). doi: 10.1002/bies.201700014. Epub 2017 Sep 8. Review.


Benchmarking selected computational gene network growing tools in context of virus-host interactions.

Taye B, Vaz C, Tanavde V, Kuznetsov VA, Eisenhaber F, Sugrue RJ, Maurer-Stroh S.

Sci Rep. 2017 Jul 19;7(1):5805. doi: 10.1038/s41598-017-06020-6.


Molecular features of influenza A (H1N1)pdm09 prevalent in Mexico during winter seasons 2012-2014.

Arellano-Llamas R, Alfaro-Ruiz L, Arriaga Canon C, Imaz Rosshandler I, Cruz-Lagunas A, Zúñiga J, Rebollar Vega R, Wong CW, Maurer-Stroh S, Romero Córdoba S, Liu ET, Hidalgo-Miranda A, Vázquez-Pérez JA.

PLoS One. 2017 Jul 10;12(7):e0180419. doi: 10.1371/journal.pone.0180419. eCollection 2017.


Systems-based approach to examine the cytokine responses in primary mouse lung macrophages infected with low pathogenic avian Influenza virus circulating in South East Asia.

Taye B, Chen H, Myaing MZ, Tan BH, Maurer-Stroh S, Sugrue RJ.

BMC Genomics. 2017 May 30;18(1):420. doi: 10.1186/s12864-017-3803-6.


Molecular and biochemical characterization of the NS1 protein of non-cultured influenza B virus strains circulating in Singapore.

Jumat MR, Wong P, Lee RT, Maurer-Stroh S, Tan BH, Sugrue RJ.

Microb Genom. 2016 Aug 25;2(8):e000082. doi: 10.1099/mgen.0.000082. eCollection 2016 Aug.


Molecular Evidence of Transmission of Influenza A/H1N1 2009 on a University Campus.

Virk RK, Gunalan V, Lee HK, Inoue M, Chua C, Tan BH, Tambyah PA.

PLoS One. 2017 Jan 6;12(1):e0168596. doi: 10.1371/journal.pone.0168596. eCollection 2017.


Viral factors in influenza pandemic risk assessment.

Lipsitch M, Barclay W, Raman R, Russell CJ, Belser JA, Cobey S, Kasson PM, Lloyd-Smith JO, Maurer-Stroh S, Riley S, Beauchemin CA, Bedford T, Friedrich TC, Handel A, Herfst S, Murcia PR, Roche B, Wilke CO, Russell CA.

Elife. 2016 Nov 11;5. pii: e18491. doi: 10.7554/eLife.18491.


Dynamic Convergent Evolution Drives the Passage Adaptation across 48 Years' History of H3N2 Influenza Evolution.

Chen H, Deng Q, Ng SH, Lee RT, Maurer-Stroh S, Zhai W.

Mol Biol Evol. 2016 Dec;33(12):3133-3143. Epub 2016 Sep 7.


Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2014-2015.

Hurt AC, Besselaar TG, Daniels RS, Ermetal B, Fry A, Gubareva L, Huang W, Lackenby A, Lee RT, Lo J, Maurer-Stroh S, Nguyen HT, Pereyaslov D, Rebelo-de-Andrade H, Siqueira MM, Takashita E, Tashiro M, Tilmanis D, Wang D, Zhang W, Meijer A.

Antiviral Res. 2016 Aug;132:178-85. doi: 10.1016/j.antiviral.2016.06.001. Epub 2016 Jun 3. Review.


Influenza infection in human host: challenges in making a better influenza vaccine.

Virk RK, Gunalan V, Tambyah PA.

Expert Rev Anti Infect Ther. 2016;14(4):365-75. doi: 10.1586/14787210.2016.1155450. Epub 2016 Mar 7. Review.


Discovery of Influenza A Virus Sequence Pairs and Their Combinations for Simultaneous Heterosubtypic Targeting that Hedge against Antiviral Resistance.

Wee KB, Lee RT, Lin J, Pramono ZA, Maurer-Stroh S.

PLoS Comput Biol. 2016 Jan 15;12(1):e1004663. doi: 10.1371/journal.pcbi.1004663. eCollection 2016 Jan.


Comparison of microarray-predicted closest genomes to sequencing for poliovirus vaccine strain similarity and influenza A phylogeny.

Maurer-Stroh S, Lee CW, Patel C, Lucero M, Nohynek H, Sung WK, Murad C, Ma J, Hibberd ML, Wong CW, Simões EA.

Diagn Microbiol Infect Dis. 2016 Mar;84(3):203-6. doi: 10.1016/j.diagmicrobio.2015.11.003. Epub 2015 Nov 6.


Evolutionary trajectories and diagnostic challenges of potentially zoonotic avian influenza viruses H5N1 and H9N2 co-circulating in Egypt.

Naguib MM, Arafa AS, El-Kady MF, Selim AA, Gunalan V, Maurer-Stroh S, Goller KV, Hassan MK, Beer M, Abdelwhab EM, Harder TC.

Infect Genet Evol. 2015 Aug;34:278-91. doi: 10.1016/j.meegid.2015.06.004. Epub 2015 Jun 3.


Influenza A(H5N8) Virus Similar to Strain in Korea Causing Highly Pathogenic Avian Influenza in Germany.

Harder T, Maurer-Stroh S, Pohlmann A, Starick E, Höreth-Böntgen D, Albrecht K, Pannwitz G, Teifke J, Gunalan V, Lee RT, Sauter-Louis C, Homeier T, Staubach C, Wolf C, Strebelow G, Höper D, Grund C, Conraths FJ, Mettenleiter TC, Beer M.

Emerg Infect Dis. 2015 May;21(5):860-3. doi: 10.3201/eid2105.141897.


Correction for Joseph et al., Adaptation of pandemic H2N2 influenza A viruses in humans.

Joseph U, Linster M, Suzuki Y, Krauss S, Halpin RA, Vijaykrishna D, Fabrizio TP, Bestebroer TM, Maurer-Stroh S, Webby RJ, Wentworth DE, Fouchier RA, Bahl J, Smith GJ.

J Virol. 2015 Apr;89(8):4706. doi: 10.1128/JVI.00259-15. No abstract available.


Influenza viruses with B/Yamagata- and B/Victoria-like neuraminidases are differentially affected by mutations that alter antiviral susceptibility.

Farrukee R, Leang SK, Butler J, Lee RT, Maurer-Stroh S, Tilmanis D, Sullivan S, Mosse J, Barr IG, Hurt AC.

J Antimicrob Chemother. 2015 Jul;70(7):2004-12. doi: 10.1093/jac/dkv065. Epub 2015 Mar 18.


Supplemental Content

Loading ...
Support Center